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Abstract
Background: In vitro studies using the myogenic cell line C2C12 demonstrate that bone morphogenetic protein-2
(BMP-2) converts the developmental pathway of C2C12 from a myogenic cell lineage to an osteoblastic cell
lineage. Further, in vivo studies using null mutation mice demonstrate that BMPs inhibit the specification of the
developmental fate of myogenic progenitor cells. However, the roles of BMPs in the phases of differentiation and
maturation in skeletal muscles have yet to be determined. The present study attempts to define the function of
BMP-2 in the final stage of differentiation of mouse tongue myoblast.
Results: Recombinant BMP-2 inhibited the expressions of markers for the differentiation of skeletal muscle cells,
such as myogenin, muscle creatine kinase (MCK), and fast myosin heavy chain (fMyHC), whereas BMP-2 siRNA
stimulated such markers. Neither the recombinant BMP-2 nor BMP-2 siRNA altered the expressions of markers for
the formation of cartilage and bone, such as osteocalcin, alkaline phosphatase (ALP), collagen II, and collagen X.
Further, no formation of cartilage and bone was observed in the recombinant BMP-2-treated tongues based on
Alizarin red and Alcian blue stainings. Neither recombinant BMP-2 nor BMP-2 siRNA affected the expression of
inhibitor of DNA binding/differentiation 1 (Id1). The ratios of chondrogenic and osteogenic markers relative to
glyceraldehyde-3-phosphate dehydrogenase (GAPDH, a house keeping gene) were approximately 1000-fold lower
than those of myogenic markers in the cultured tongue.
Conclusions: BMP-2 functions as a negative regulator for the final differentiation of tongue myoblasts, but not as
an inducer for the formation of cartilage and bone in cultured tongue, probably because the genes related to
myogenesis are in an activation mode, while the genes related to chondrogenesis and osteogenesis are in a
silencing mode.
Background
The development of skeletal muscle proceeds through
five phases, as follows [1]: phase 1 (specification), muscle
progenitor cells are specified to become muscle cells in
somites; phase 2 (migration), the muscle progenitor cells
migrate to the presumptive places where muscles are
formed; phase 3 (proliferation), the muscle progenitor
cells proliferate, increase in number, and become myo-
blasts; phase 4 (differentiation), the myoblasts fuse to
become multinucleated myotubes; phase 5 (maturation),
the multinucleated myotubes mature to myofibers, such
as fast-twitch myofibers or slow-twitch myofibers.
Bone morphogenetic proteins (BMPs) are members of
the transforming growth factor b (TGFb)s u p e rf a m i l y
and comprise a highly conserved and expanding family
of 15 genes. BMPs were discovered as a factor that
induced the ectopic formation of cartilage and bone
when implanted intramuscularly in adult rats [2,3].
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biological functions [4-6] including in the development
of skeletal muscle.
In vitro studies using the myogenic cell line C2C12
demonstrate that BMP-2 converts the developmental
pathway of C2C12 from a myogenic lineage to an
osteoblastic lineage by reducing the activity of the
myoD family, such as that of myoD and myogenin, and
by up-regulating inhibitor of DNA binding/differentia-
tion 1 (Id1) and runt-related gene 2 (Runx2) [7-11].
This conversion of the developmental pathway of
C2C12 seems to inhibit myogenic differentiation,
including myotube formation. In vivo studies using
null mutation mice demonstrate that BMPs inhibit the
specification of the developmental fate of myogenic
progenitor cells: BMPs from the lateral plate and dor-
sal neural tube inhibit the specification in the somites
and somitomeres [12-17], and Noggin (a BMP antago-
nist) suppresses the action of BMPs [18-20]. We
recently reported that BMPs and their receptors are
expressed in the myoblasts and myotubes of mouse
embryonic tongues which are actively differentiating
and maturating, implying that BMPs play a role in
myoblast differentiation [21].
The tongue is a complex muscular organ comprised
of several intrinsic and extrinsic muscles, and is
involved in several important physiological tasks, such
as suckling, swallowing, mastication, respiration, and
vocalization. The tongue muscles constitute a subset
of the head muscles, but several lines of evidence
indicate that the program governing tongue myogen-
esis is more similar to those for migratory hypaxial
muscles, such as the limb and diaphragm muscles,
than to the head muscles, such as the masseter and
temporalis muscles [22,23]. We have extensively stu-
died the roles of peptide growth factors such as insu-
lin-like growth factor (IGF) [24] and hepatocyte
growth factor (HGF) in the development of tongue
muscle cells using an organ culture system of mouse
e m b r y o n i ct o n g u e[ 2 5 , 2 6 ] .T h eo r g a nc u l t u r es y s t e m
of mouse embryonic tongue seems to be a good
model for studying the genetic program governing
migratory hypaxial myogenesis and for relating the
results of in vivo studies with those of in vitro studies
using established myogenic cell lines such as C2C12.
However, the roles of BMPs in the phases of differen-
tiation and maturation in skeletal muscles have yet to
be fully elucidated. The present study attempts to
define the functions of BMP-2 in the differentiation
phase of myoblasts in mouse embryonic tongue using
an organ culture system of embryonic day (E) 13
m o u s et o n g u ei nw h i c ht h ed i f f e r e n t i a t i o np h a s eo f
myoblasts is initiated [23].
Results
Recombinant BMP-2 had neither inhibitory nor
proliferative effects on cultured tongue
To identify possible toxic effects of recombinant BMP-2
on cultured tongue, we observed the gross morphology
of E13 tongues cultured for 8 days in BGJb medium
containing vehicle (Figure 1A) or recombinant BMP-2
( F i g u r e1 B ) .N os i g n i f i c a n td i f f e r e n c ei nt h es h a p eo r
size was observed between the vehicle- and recombinant
BMP-2-treated tongue. To estimate the whole tissue
volume of the cultured tongues, we measured the
expression level of the mRNA of glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH), a house keeping gene
(Figure 1C). No marked difference was found between
the expression level of GAPDH mRNA stimulated by
the vehicle and that stimulated by recombinant BMP-2,
s u g g e s t i n gt h a tt h er e c o m b i n a n tB M P - 2h a dn oi n h i b i -
tory effect on the cultured tongues. Furthermore, we
analyzed the mRNA expression levels of cyclin D1 (Fig-
ure 1D) and cyclin-dependent kinase 4 (CDK4) (Figure
1E), markers for the proliferation of cells, and found no
significant difference between the vehicle and recombi-
nant BMP-2, suggesting that recombinant BMP-2 did
not alter the proliferation of cells in the cultured
tongues.
Recombinant BMP-2 suppressed the differentiation of
myoblasts in cultured tongue
To identify the role of BMP-2 in the differentiation of
tongue myoblasts, we supplemented human recombi-
nant BMP-2 in the culture medium and analyzed the
mRNA expression levels of myoD, myogenin, and
muscle creatine kinase (MCK), markers for muscle dif-
ferentiation, in the cultured tongue (Table 1 and
Additional file 1). The ratios of myogenin and MCK, a
marker for the final stages of muscle differentiation,
relative to GAPDH in the recombinant BMP-2-treated
tongues were 0.0180 ± 0.00162 and 0.0414 ± 0.00737,
respectively, which were approximately 30 and 38%
lower than those in the vehicle-treated tongues
(0.0256 ± 0.00510 and 0.0661 ± 0.0149, respectively; p
< 0.01). No significant difference in the expression
level of myoD was found between the samples treated
with the vehicle and those treated with recombinant
BMP-2.
To further verify whether the recombinant BMP-2
suppressed the differentiation of tongue myoblasts in
cultured tongues, we analyzed the localization and
expression level of myogenin and fast myosin heavy
chain (fMyHC) proteins in the recombinant BMP-2- or
vehicle-treated tongues by immunohistochemical and
Western blotting analyses (Figure 2). The number of
myogenin-positive cells appeared to be lower in the
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Page 2 of 12Figure 1 Recombinant BMP-2 had neither inhibitory nor proliferative effects on cultured tongue. Gross morphology of E13 tongues
cultured for 8 days in BGJb medium containing vehicle (A) and 4 μg/ml of human recombinant BMP-2 (B). B used the same magnification as A.
Expression level of GAPDH mRNA in E13 tongues cultured for 8 days in BGJb medium containing vehicle and 4 μg/ml of human recombinant
BMP-2 (C). The longitudinal axis in C represents the quantity of GAPDH mRNA contained in one cultured tongue. Expression levels of cyclin D1
(D) and CDK4 (E) mRNAs in E13 tongues cultured for 8 days in BGJb medium containing vehicle and 4 μg/ml of human recombinant BMP-2.
The longitudinal axis in D and E represents the ratio of target gene mRNA relative to GAPDH mRNA. Each column and vertical bar represent the
mean + 1SD of six cultured tongues.
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Page 3 of 12BMP-2-treated tongue (arrows in Figure 2B) than in the
vehicle-treated tongue (arrows in Figure 2A). Elongated
myotubes with multi-nuclei were nearly absent in the
BMP-2-treated tongues (arrowheads in Figure 2D),
whereas they were clearly present in the vehicle-treated
tongue (arrowheads in Figure 2C). The expression levels
of myogenin and fMyHC proteins were lower in the
BMP-2-treated tongue than in the vehicle-treated ton-
gue (Figure 2E).
Recombinant BMP-2 did not induce the formation of
cartilage and bone in cultured tongue
To determine whether recombinant BMP-2 induced
the formation of cartilage and bone in the cultured
tongue, we analyzed the mRNA expression levels of
Runx2, alkaline phosphatase (ALP), collagen II, and
collagen X, which are markers for chondrogenesis and
osteogenesis (Table 1 and Additional file 1). In the
BMP-2-treated tongue, Runx2 mRNA was induced, but
the ratio of Runx2 relative to GAPDH was extremely
low and approximately 1000-fold lower than those of
myogenic markers such as myoD, myogenin, and
MCK. There was no significant difference in the
mRNA expression levels of osteocalcin, ALP, collagen
II, and collagen X between the recombinant BMP-2
and vehicle-treated tongues. Their ratios relative to
GAPDH were also extremely low, being approximately
1000-fold lower than those of the myogenic markers,
and the variations for measurement were also quite
large.
To further determine whether recombinant BMP-2
induced the formation of cartilage and bone in the cul-
tured tongue, we stained the cultured tongue using Ali-
zarin red (Figure 3A, B, C) and Alcian blue (Figure 3D,
E, F). No Alizarin red-positive staining was observed in
any sample, but a weak, nearly identical Alcian blue-
positive staining was observed in both the BMP-2- and
vehicle-treated tongues.
Suppression of BMP-2 expression by siRNA had neither
inhibitory nor proliferative effects on cultured tongue
The addition of BMP-2 siRNA to the cultured medium
induced an approximately 50% suppression of the
expression of BMP-2 mRNA (Figure 4A), but no sup-
pression in BMP-4 mRNA (Figure 4B). The result of
immunohistochemical and Western blotting analyses
indicated that BMP-2 siRNA induced a marked suppres-
sion in the expression of BMP-2 protein compared with
non-target control RNA (NTC) (Figure 4C, D, E). The
suppression of BMP-2 by siRNA induced no significant
difference in the gross morphology of the cultured ton-
gue (Figure 4F, G). Neither was there a significant differ-
ence in the expressions of GAPDH (Figure 4H), cyclin
D1 (Figure 4I), and CDK4 (Figure 4J) between the sam-
ples treated with NTC and those treated with BMP-2
siRNA, suggesting that BMP-2 siRNA had neither inhi-
bitory nor proliferative effects on cultured tongue.
BMP-2 siRNA stimulated the differentiation of myoblasts
in cultured tongue
To determine the role of BMP-2 in the differentiation of
tongue myoblasts, we analyzed the effect of BMP-2
siRNA on the mRNA expression levels of myoD, myo-
genin, and MCK in cultured tongue (Table 2 and Addi-
tional file 1). The ratios of myogenin and MCK relative
to GAPDH in the BMP-2 siRNA-treated tongues were
0.0203 ± 0.0037 and 0.116 ± 0.0275, respectively, which
were approximately 60 and 80% higher than those in
the NTC-treated tongues (0.0128 ± 0.0044 and 0.0646 ±
0.0251, respectively; p < 0.01). No significant difference
in the expression levels of myoD was found between the
NTC- and BMP-2 siRNA-treated cultures.
To further verify whether BMP-2 siRNA could stimu-
late the differentiation of myoblasts in cultured tongues,
we analyzed the immunolocalization and expression
levels of myogenin and fMyHC proteins in the NTC-
and BMP-2 siRNA-treated tongues (Figure 5). The
Table 1 mRNA levels for genes related to myogenesis, chondrogenesis, and osteogenesis in vehicle- and BMP-2-
treated tongues
Genes Vehicle Recombinant BMP-2 Significance
Myogenesis
MyoD 0.0163 ± 0.00616 0.0172 ± 0.00467 NS
Myogenin 0.0256 ± 0.00510 0.0180 ± 0.00162 p < 0.01
MCK 0.0661 ± 0.0149 0.0414 ± 0.00737 p < 0.01
Chondrogenesis, osteogenesis
Runx2 0 0.0000661 ± 0.0000800 NS
Osteocalcin 0.0000514 ± 0.0000552 0.0000581 ± 0.0000535 NS
ALP 0.000813 ± 0.000632 0.000700 ± 0.000576 NS
Collagen II 0.000167 ± 0.00246 0.000535 ± 0.0105 NS
Collagen X 0.000129 ± 0.00123 0.000155 ± 0.00168 NS
The mean ± standard deviation of six vehicle-treated or six BMP-2-treated tongues for each gene is shown. The ratio of each target gene mRNA relative to
GAPDH mRNA is shown.
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Page 4 of 12number of myogenin-positive cells appeared to be
higher in the BMP-2 siRNA-treated tongue (arrows in
Figure 5B) than in the NTC-treated tongue (arrows in
Figure 5A). There were more elongated myotubes with
multi-nuclei in the BMP-2 siRNA-treated tongues (Fig-
ure 5D) than in the NTC-treated tongue (Figure 5C).
The expression levels of myogenin and fMyHC proteins
were higher in the BMP-2 siRNA-treated tongue than in
the NTC-treated tongue (Figure 5E).
Suppression of BMP-2 expression by siRNA did not affect
the formation of cartilage and bone in cultured tongue
To elucidate the effect of BMP-2 siRNA on the forma-
tion of cartilage and bone in cultured tongue, we ana-
lyzed the mRNA expression levels of Runx2, osteocalcin,
ALP, collagen II, and collagen X, which are markers for
chondrogenesis and osteogenesis (Table 2 and Addi-
tional file 1). Neither BMP-2 siRNA- nor NTC-treated
tongue induced detectable levels of Runx2 mRNA.
Figure 2 Recombinant BMP-2 suppressed the expressions of myogenin and fMyHC in cultured tongue. Immunostaining image for
myogenin (A, B) and fMyHC (C, D) in the middle portion of E13 tongues cultured for 8 days in BGJb medium containing the vehicle (A, C) and
4 μg/ml of recombinant BMP-2 (B, D). Brown color indicates immunostaining image for myogenin and fMyHC. Arrows in A and B indicate
myogenin-positive nuclei and arrowheads in C and D indicate elongated myotubes and myofibers. Western blotting pattern of myogenin,
fMyHC, and bIII-tubulin in the whole portion of E13 tongues cultured for 8 days in BGJb medium containing the vehicle and 4 μg/ml of
recombinant BMP-2 (E).
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mRNA expression levels of osteocalcin, ALP, collagen II,
and collagen X between the NTC- and BMP-2 siRNA-
treated tongues. Their ratios relative to GAPDH were
also extremely low, being approximately 1000-fold lower
than those of the myogenic markers, and the variations
for measurement were also large.
Neither recombinant BMP-2 nor BMP-2 siRNA altered the
expression of Id1
Since BMP-2 suppressed the differentiation of C2C12
myogenic cells by reducing the activity of the myoD
family, such as myoD and myogenin, via up-regulation
of Id1 [7-9], we analyzed the effects of recombinant
BMP-2 and BMP-2 siRNA on the mRNA expression
levels (Table 3 and Additional file 1). We found no
marked difference in the mRNA expression levels of Id1
between the vehicle- and recombinant BMP-2-treated
tongues, or between the NTC- and BMP-2 siRNA-trea-
ted tongues.
Discussion
In vitro studies using the myogenic cell line C2C12
demonstrate that BMP-2 converts the developmental
pathway of C2C12 from a myogenic lineage to an osteo-
blastic lineage [7-11], whereas in vivo studies using null
mutation mice demonstrate that BMPs inhibit the speci-
fication of the developmental fate of myogenic progeni-
tor cells [12-17]. However, the roles of BMPs in the
phases of differentiation and maturation in skeletal mus-
cles have remained elusive. In the present study, recom-
binant BMP-2 suppressed the expressions of markers
for the differentiation of skeletal muscle cells in cultured
E13 tongue, whereas the suppression of BMP-2 with
siRNA stimulated them, suggesting that BMP-2 func-
tions as a negative regulator in the final differentiation
of tongue myoblasts.
BMPs were first discovered as a factor that induced
ectopic cartilage formation when implanted intramuscu-
larly in adult rats [2,3]. However, in the present study,
the formation of cartilage and bone was not observed in
cultured tongue treated with recombinant BMP-2, and
neither the recombinant BMP-2 nor BMP-2 siRNA
altered the expression of markers for the formation of
cartilage and bone, such as osteocalcin, ALP, collagen II,
and collagen X. Collectively, these results suggest that
BMP-2 functions as a negative regulator in the final dif-
ferentiation of tongue myoblasts, but not as an inducer in
the formation of cartilage and bone in cultured tongue.
In the present study, the transcriptional levels of
chondrogenic and osteogenic markers were approxi-
mately 1000-fold lower than those of the myogenic
Figure 3 Recombinant BMP-2 did not induce the formation of cartilage and bone in cultured tongue. Staining images with Alizarin red
(A, B, C) and Alcian blue (D, E, F) in the middle portion of E13 tongues cultured for 8 days in BGJb medium containing the vehicle (A, D) and 4
μg/ml of recombinant BMP-2 (B, E). Staining images of longitudinal section of hind limb containing tibia and fibula of E17 embryo and Meckel’s
cartilage of E11 embryo are shown as a positive control of Alizarin red and Alcian blue in C and F, respectively. B, D, and E used the same
magnification as A.
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Page 6 of 12Figure 4 BMP-2 siRNA suppressed the expression of BMP-2, but had neither inhibitory nor proliferative effects. Expression levels of
BMP-2 (A) and BMP-4 (B) mRNAs in E13 tongues cultured for 8 days in BGJb medium containing 250 nM of NTC and BMP-2 siRNA.
Immunostaining image for BMP-2 in the middle portion of E13 tongues cultured for 8 days in BGJb medium containing NTC (C) and BMP-2
siRNA (D). Western blotting pattern of BMP-2 and bIII-tubulin in the whole portion of E13 tongues cultured for 8 days in BGJb medium
containing the NTC and BMP-2 siRNA (E). Gross morphology of E13 tongues cultured for 8 days in BGJb medium containing NTC (F) and BMP-2
siRNA (G). Expression level of GAPDH mRNA in cultured E13 tongues (H). The longitudinal axis in H represents the quantity of GAPDH mRNA
contained in one cultured tongue. Expression levels of cyclin D1 (I) and CDK4 (J) mRNAs in cultured E13 tongues. The longitudinal axis in I and J
represents the ratio of target gene mRNA relative to GAPDH mRNA. Each column and vertical bar represent the mean + 1SD of six cultured
tongues.
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Page 7 of 12markers, implying that the genes involved in myogenesis
a r ei na na c t i v a t i o nm o d e ,w h i l et h eg e n e si n v o l v e di n
chondrogenesis and osteogenesis are in a silencing
mode. There may be several candidate mechanisms to
regulate the status of gene expression. It was recently
reported that epigenetic regulation, such as via the
methylation and acetylation of histone, and the methyla-
tion of DNA, plays essential roles in the development
and regeneration of several kinds of tissues [27,28].
Additionally, in the development of skeletal muscle, the
transcription of myogenin, myoD, and MCK is reported
to be regulated by the methylation or de-methylation of
histone during myogenesis [29-31]. The silencing of
genes involved in chondrogenesis and osteogenesis by
epigenetic regulation is a good potential candidate
mechanism suggesting that BMP-2 does not function as
an inducer in the formation of cartilage and bone in cul-
tured E13 tongue. To fully elucidate this issue, further
studies will be necessary.
In vitro studies using myogenic cell line C2C12
demonstrate that BMP-2 converts the developmental
pathway of C2C12 via an elevation in the expression of
Id1 which suppresses the activity of the myoD family
[7-11,32]. However, in the present study, the recombi-
nant BMP-2 or BMP-2 siRNA did not induce an altera-
tion in the expression of Id1, suggesting the existence of
a different pathway(s) for the regulation of tongue
striated muscle cells from C2C12 myogenic cells. The
myoD family is known to play an essential role in the
development of tongue muscle cells, but there is no
report on the function of Id1 in these cells [23], and the
molecular mechanism of the interaction between Id1
and the myoD family during the development of tongue
muscle cells remains unknown.
We previously reported several different functions of
peptide growth factors in the development of tongue
muscle cells from limb and cultured myogenic cell lines:
TGFa promotes early differentiation of mouse tongue
myoblasts [33-35], whereas it does not affect the differ-
entiation of the C2C12 myoblast [36]; and the signal of
TGFb3, but not of 1 or 2, plays a role in the early stages
i nt h ed i f f e r e n t i a t i o no fm o u s et o n g u em u s c l ec e l l s
through TGFb receptor I, TGFb receptor II, and smad2/
3 [37], but TGFb1 inhibits the differentiation of limb
skeletal muscle cells [38,39]. In addition to the function
of growth factors, there are several studies showing
other differences between tongue muscle cells, and limb
and cultured myogenic cell lines, such that fMyHC is
expressed not only in the myotubes and myofibers of
tongue muscles but also in the myoblasts of tongue
muscles, although it is not expressed in the myoblasts of
trunk and limb muscles [40]. Our present result offers
support for the theory that the program governing ton-
gue myogenesis is more similar to those for limb and
cultured myogenic cell lines than for head muscles,
although it still differs from the former.
The coefficients of variance for the mRNA expression
levels of genes related to myogenesis ranged from 9.1 to
38.9%, whereas those for genes related to osteogenesis
and chondrogenesis ranged from 18.0 to 197.1%. The
ratios relative to GAPDH of the osteogenic and chon-
drogenic marker mRNAs were extremely low, being
approximately 1000-fold lower than those of the myo-
genic marker mRNAs. Since these values of the osteo-
genic and chondrogenic marker mRNAs appeared at
near the detection limit for real-time polymerase chain
reaction (PCR) analysis, the extreme low level of expres-
sion may reflect marked variation.
Conclusions
In vitro studies using the myogenic cell line C2C12
demonstrate that BMP-2 converts the developmental
pathway of C2C12 from a myogenic lineage to an osteo-
blastic lineage [7-11], whereas in vivo studies using null
mutation mice demonstrate that BMPs inhibit the speci-
fication of the developmental fate of myogenic
Table 2 mRNA levels for genes related myogenesis, chondrogenesis, and osteogenesis in NTC- and BMP-2 siRNA-
treated tongues
Genes NTC BMP-2 siRNA Significance
Myogenesis
MyoD 0.0130 ± 0.00452 0.0136 ± 0.00515 NS
Myogenin 0.0128 ± 0.0044 0.0203 ± 0.0037 p < 0.01
MCK 0.0646 ± 0.0251 0.116 ± 0.0275 p < 0.01
Chondrogenesis, osteogenesis
Runx2 0 0 NS
Osteocalcin 0.0000406 ± 0.0000632 0.0000356 ± 0.0000795 NS
ALP 0.00291 ± 0.00455 0.00365 ± 0.00460 NS
Collagen II 0.000202 ± 0.000333 0.0000435 ± 0.0000529 NS
Collagen X 0.000674 ± 0.000690 0.000264 ± 0.000265 NS
The mean ± standard deviation of six vehicle-treated or six BMP-2-treated tongues for each gene is shown. The ratio of each target gene mRNA relative to
GAPDH mRNA is shown.
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Page 8 of 12progenitor cells [12-17]. In the present study, BMP-2
functioned as a negative regulator for the final differen-
tiation of tongue muscle cells, but not as an inducer for
the formation of cartilage and bone in cultured E13 ton-
gue, probably because the genes related to myogenesis
are in an activation mode, while the genes related to
chondrogenesis and osteogenesis are in a silencing mode.
Methods
Experimental animal
Pregnant ICR mice were purchased from Nippon Clea
Co., Ltd. (Tokyo, Japan) and killed by cervical disloca-
tion at E13. Embryos were isolated from uterine decidua
and were removed from their membranes under a dis-
section microscope. Tongues for PCR analysis were
Figure 5 BMP-2 siRNA induced the expressions of myogenin and fMyHC in cultured tongue. Immunostaining images for myogenin (A, B)
and fMyHC (C, D) in the middle portion of E13 tongues cultured for 8 days in BGJb medium containing 250 nM of the NTC (A, C) and BMP-2
siRNA (B, D). Brown color indicates immunostaining image for myogenin and fMyHC. Arrows in A and B indicate myogenin-positive nuclei.
Western blotting pattern of myogenin, fMyHC, and bIII-tubulin in the whole portion of E13 tongues cultured for 8 days in BGJb medium
containing the NTC and BMP-2 siRNA (E).
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Page 9 of 12removed, immediately frozen, and then stored at -80°C
until use. Experimental protocols concerning animal
handling were reviewed and approved by the Institu-
tional Animal Care Committee of Tsurumi University
School of Dental Medicine.
Organ culture
Tongues of the E13 embryos were carefully microdis-
sected and explanted. The explants were supported by
membrane filters having a 0.8 μm pore size (type AABP,
Millipore Corp., Bedford, MA, USA) on steel rafts and
were cultured in BGJb medium (Life Technologies,
Rockville, MD, USA). The cultures were maintained at
37°C in an atmosphere of 5% carbon dioxide and 95%
air with medium changes every 2 days. Human recombi-
nant BMP-2 (R&D Systems, Inc., Minneapolis, MN,
USA) in the vehicle (4 mM HCl, 0.15% bovine serum
albumin) or the vehicle only was supplemented to the
culture BGJb medium at a final concentration of 4 μg/
ml of human recombinant BMP-2. A cocktail compris-
ing four kinds of BMP-2 siRNA (GAACACAGCUGGU-
CACAGAUU, GCAGCCAACUUGAAAUUUCUU,
GCAAGAGACACCCUUUGUAUU, and CCACAGAG-
CUCAGCGCAAUUU) and NTC was purchased from
GE Healthcare UK, Ltd. (Buckinghamshire, England).
They were mixed with a cationic agent, oligofectamine
(Invitrogen, Carlsbad, CA, USA), and were added to the
culture BGJb medium at a final concentration of 250
nM. After 8 days in the culture, the explants were
rapidly frozen and stored at -85°C until subsequent total
RNA extraction, or immediately fixed in Bouin’so r4 %
paraformaldehyde solution for immunohistochemistry.
RNA extraction, reverse transcription, and real-time PCR
amplification
Total RNA extraction, reverse transcription (RT), and
real-time PCR amplification were performed according
to the manufacturer’s specifications (Trizol, Life Tech-
nologies, Gaithersburg, MD, USA). The RNA was trea-
ted with 2 units of ribonuclease-free deoxyribonuclease I
(Life Technologies, Gaithersburg, MD, USA), and was
then reverse transcribed with 200 units of reverse
transcriptase (SuperScript II, Life Technologies,
Gaithersburg, MD, USA).
SYBR Green real-time PCR was performed on the
Takara PCR Thermal Cycler Dice (Takara Bio, Inc.,
Shiga, Japan) using the following cycle parameters for all
genes studied: denaturation at 95°C for 10 min, followed
by 40 cycles of 95°C for 15 s for denaturation, and 55°C
for 15 s for annealing and extension. The nucleotide
sequences for the primers of all target genes are shown
in Table 4. The mRNA quantity of each gene was calcu-
lated using a standard curve of the known concentra-
tions of cDNA of each gene and were normalized by the
quantity of GAPDH mRNA, a housing keeping gene.
We disclosed the details of real-time PCR conditions in
Additional file 2 following minimum information for
publication of quantitative real-time PCR experiments
(MIQE).
Histochemistry
Sagittal sections of cultured tongues were prepared at
a1 0μm thickness with a cryostat. Immuno-enzyme
stainings were performed as previously described
Table 3 mRNA levels of Id1
Vehicle- and BMP-2-treated tongues
Genes Vehicle Recombinant BMP-2 Significance
Id1 0.000517 ± 0.000133 0.00054 ± 0.000184 NS
NTC- and BMP-2 siRNA-treated tongues
NTC BMP-2 siRNA
Id1 0.000454 ± 0.000264 0.000381 ± 0.000149 NS
The mean ± standard deviation of six vehicle-treated or six BMP-2-treated
tongues for each gene is shown. The ratio of each target gene mRNA relative
to GAPDH mRNA is shown.
Table 4 Sequences of primer specific for target genes
Genes
MyoD Forward 5’-GAC GGC TCT CTC TGC TCC-3’
Reverse 5’-AAG TGT GCG TGC TCC TCC-3’
Myogenin Forward 5’-GAG CGC GAT CTC CGC TAC AGA GG-3’
Reverse 5’-CTG GCT TGT GGC AGC CCA GG-3’
MCK Forward 5’-CAA TAA GCT TCG CGA TAA GGA G-3’
Reverse 5’-GAT GGG ATC AAA CAG GTC CTT G-3’
Id1 Forward 5’-ACG ACA TGA ACG GCT GCT ACT-3’
Reverse 5’-GCT CAC TTT GCG GTT CTG G-3’
Runx2 Forward 5’-TTT AGG GCG CAT TCC TCA TC-3’
Reverse 5’-TGT CCT TGT GGA TTA AAA GGA CTT G-3’
Osteocalcin Forward 5’-TGC TTG TGA CGA GCT ATC AG-3’
Reverse 5’-GAG GAC AGG GAG GAT CAA GT-3’
ALP Forward 5’-CAC GGG CAC CAT GAA GGA AAA G-3’
Reverse 5’-TGG CGC AGG GGC ACA GGA GAC T-3’
Collagen II Forward 5’-ACT GGT AAG TGG GGC AAG AC-3’
Reverse 5’-CCA CAC CAA ATT CCT GTT CA-3’
Collagen X Forward 5’-TGG GTA GGC CTG TAT AAA GAA CGG-3’
Reverse 5’-CAT GGG AGC CAC TAG GAA TCC TGA GA-3’
Cyclin D1 Forward 5’-AGG CGG ATG AGA ACA AGC AGA-3’
Reverse 5’-CAG GCT TGA CTC CAG AAG GG-3’
CDK4 Forward 5’-ACG CCT GTG GTG GTT ACG CT-3’
Reverse 5’-CCA TCT CTG GCA CCA CTG AC-3’
BMP-2 Forward 5’-GTG GTG GAA GTG GCC CAC TT-3’
Reverse 5’-CTG TTT GTG TTT GGC TTG ACG-3’
BMP-4 Forward 5’-TCC TGG TAA CCG AAT GCT GAT-3’
Reverse 5’-GCT GCT GAG GTT GAA GAG GAA-3’
GAPDH Forward 5’-GAT GCT GGT GCT GAG TAT GTC G-3’
Reverse 5’-GTG GTG CAG GAT GCA TTG CTG A-3’
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Page 10 of 12[41,42]. To evaluate the differentiation of muscle cells
in the tongue tissues, we performed immunolocaliza-
tion for fMyHC and myogenin; and to evaluate the
effect of BMP-2 siRNA, we performed immunolocaliza-
tion for BMP-2 in the cultured E13 mouse tongue.
Monoclonal antibody against fMyHC was purchased
from Sigma-Aldrich, Inc. (St. Louis, MO, USA). Poly-
clonal antibodies against myogenin and BMP-2 were
purchased from Santa Cruz Biotechnology, Inc. (Santa
Cruz, CA, USA). In vivo tongue tissues at E14 were
used for positive control of fMyHC and myogenin
(Additional file 3). For control staining, the primary
antibody was replaced with normal goat, rabbit, mouse
IgG, or phosphate buffered saline (PBS). To detect
bone and cartilage formation, Alizarin red or Alcian
blue stainings were used, respectively.
Western blot analysis
Cultured tongues were homogenized in 2% SDS, 62.5
mM Tris-HCl (pH 6.8), and 10% glycerol containing
the cocktail of protease inhibitors. The homogenate
was centrifuged at 8,000 rpm for 15 minutes and the
supernatant was stored at -20°C until use. The protein
concentration of the supernatant was measured by the
B C Mp r o t e i na s s a y( P i e r c e ,R o c k f o r d ,I L ,U S A ) .A f t e r
b-mercaptoethanol was added to the supernatant (final
concentration, 5%), the supernatant was heated at 100°
C for 5 minutes. The samples containing 25 μgt o t a l
proteins were subjected to 5-20% gradient SDS-PAGE.
After electrophoresis, the proteins were transferred
onto a PVDF membrane (Hybond-P PVDF Membrane,
Amersham Biosciences Corp., Piscataway, NJ, USA).
The membranes were treated with Casein Solution
(Vector Laboratories, Inc., Burlingame, CA, USA) for 3
hours at room temperature, and then incubated over-
night at 4°C with primary antibodies. The following
primary antibodies were usedf o rW e s t e r nb l o ta n a l y s i s
in the present study: mouse monoclonal antibodies
against fMyHC (Sigma-Aldrich Inc., St. Louis, MO,
USA) and bIII-tubulin (Promega Co., Madison, WI,
USA), rabbit polyclonal antibody against myogenin,
a n dg o a tp o l y c l o n a la n t i b ody against BMP-2 (Santa
Cruz Biotechnology Inc.,S a n t aC r u z ,C A ,U S A ) .
Immunoreactions were made visible using the Vectas-
tain Elite ABC Kit and 3-amino-9-ethylcarbazole
(AEC) (Vector Laboratories, Inc.). The banding images
were captured using a digital camera (FinePix, Fujifilm
Corp., Tokyo, Japan) and transferred to a personal
computer. The intensity in the bands was measured by
a Densitograph (ATTO Corp., Tokyo, Japan). bIII-
tubulin was used as a loading control to confirm that
the same amount of protein was loaded to each lane of
SDS-PAGE.
Statistical analysis
A Mann-Whitney U test was used to compare the med-
ian values between two groups.
Additional material
Additional file 1: Relative expressions of gene mRNAs related to
myogenesis chondrogenesis, osteogenesis. Relative expression levels
of gene mRNAs related to myogenesis in E13 tongue cultured for 8 days
in BGJb containing vehicle or 4 μg/ml of human recombinant BMP-2
(upper panel), and containing 250 nM of NTC or BMP-2 siRNA (lower
panel). The longitudinal axis represents the percent value relative to the
mean value of each target gene of vehicle- or NTC-treated tongue set at
100. Each column represents the mean of six cultured tongues.
Additional file 2: The details of real-time PCR conditions. The details
of real-time PCR conditions were provided following minimum
information for publication of quantitative real-time PCR experiments
(MIQE).
Additional file 3: Positive control images for fMyHC and myogenin.
Immunostaining images for fMyHC (A) and myogenin (B) in the middle
portion of in vivo tongues dissected from mouse embryo at E14.
List of abbreviations used
ALP: alkaline phosphatase; BMPs: bone morphogenetic proteins; CDK: cyclin-
dependent kinase; E: embryonic day; fMyHC: fast myosin heavy chain;
GAPDH: glyceraldehyde-3-phosphate dehydrogenase; HGF: hepatocyte
growth factor; Id: inhibitor of DNA binding/differentiation; IGF: insulin-like
growth factor; MCK: muscle creatine kinase; MIQE: minimum information for
publication of quantitative real-time PCR experiments; NTC: non-target
control RNA; PBS: phosphate buffered saline; PCR: polymerase chain reaction;
RT: reverse transcription; Runx: runt-related gene; TGF: transforming growth
factor.
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